Give Online: Help shape patient care for generations to come.
Cleveland Clinic Logo

Nathan Kraynack, MD

216.444.5437

No Patient Satisfaction Reviews
Nathan Kraynack, MD
Department: Center for Pediatric Pulmonary Medicine
Location: Cleveland Clinic Main Campus
Mail Code A120
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.5437
DeskDesk:216.445.2200
WorkFax:216.445.7792
Nathan Kraynack, MD
Department: Center for Pediatric Pulmonary Medicine
Location: Richard E. Jacobs Health Center
Mail Code A120
33100 Cleveland Clinic Blvd.
Avon, OH 44011
WorkAppointment:216.444.5437
DeskDesk:216.445.2200
WorkFax:216.445.7792
Nathan Kraynack, MD
Department: Center for Pediatric Pulmonary Medicine
Location: Twinsburg Family Health & Surgery Center
Mail Code A120
8701 Darrow Road
Twinsburg, OH 44087
WorkAppointment:216.444.5437
DeskDesk:216.445.2200
WorkFax:216.445.7792
Surgeon:
No
Type of Doctor:
Children & Adolescents Only

Biographical Sketch

Nathan C. Kraynack, M.D. was appointed to Cleveland Clinic Children’s in 2013 to the Department of Pediatrics ND Center for Pediatric Pulmonary Medicine. He is the Medical Director of the Pediatric Solid Organ Transplant and Pediatric Lung Transplant Programs. 

He has been board-certified in pediatrics and pediatric pulmonary medicine. He cares for children and young adults with all forms of pediatric lung conditions such as asthma, bronchopulmonary dysplasia, chronic lung disease of prematurity, chronic respiratory failure, and those children requiring technological assistance to breathe effectively. In particular, he has a keen interest in children with Cystic Fibrosis, other forms of bronchiectasis, end stage lung disease and those requiring or having had a lung transplant.

Serving as the head of a large accredited Cystic Fibrosis Center for almost ten years, he has a wealth of experience in caring for these patients with their complex medical needs. He and his team realized that inconsistent care for this condition across Cystic Fibrosis Care Center was prevalent and may be contributing to variable outcomes1. Heading a multidisciplinary team of caregivers, his team developed standardized protocols for cystic fibrosis care that had not previously been used and were associated with dramatic improvement in patient outcomes at their center2. These protocols have since been adopted at other care centers nationally and internationally on at least three continents. His passion for standardized care has extended to nutritional protocols for patients with cystic fibrosis, non-cystic fibrosis bronchiectasis, inpatient management for patients with cystic fibrosis, asthma, and those patients with chronic respiratory failure and lung transplantation.  

Dr. Kraynack has been named one of the Best Doctors in America since 2009. He has been a principal investigator of translational research trials and a number of multicenter clinical trials for patients with Cystic Fibrosis.  He is the Pediatric Representative for the Transplant Center Advisory Council at Cleveland Clinic. As an Associate Professor of Pediatrics at the Cleveland Clinic Lerner College of Medicine and Case Western University and the Northeast Ohio Medical University (Rootstown, OH), he is active in medical education of medical students and pediatric resident physicians.

An invited lecturer at national and international medical meetings, Dr. Kraynack is a recognized expert in the field of Cystic Fibrosis and the implementation of Quality Improvement programs to improve patient outcomes.

Education & Fellowships

Fellowship - Rainbow, Babies & Children University Hospitals
Pediatric Pulmonology
Cleveland, OH USA
2003
Residency - Rainbow, Babies & Children University Hospitals
Pediatrics
Cleveland, OH USA
2000
Medical School - Georgetown University School of Medicine
Washington, DC USA
1997
Undergraduate - University of Pennsylvania
Philadelphia, PA USA
1993

Certifications

  • Pediatrics
  • Pediatrics- Pediatric Pulmonology

Treatment & Services

  • Bronchial Biopsy
  • Bronchoscopy
  • Center for Pediatric Pulmonology
  • Spirometry

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 5/13/2016, Dr. Kraynack has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English